InsidersTradesSigma
Follow the 삼익제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼익제약 has logged 5 public disclosures. Market capitalisation: €41.1bn. The latest transaction was reported on 25 June 2026 (Sale). Among the most active insiders: 권영이. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
€76,464
1 ops.
Buy Volume
€89,675
4 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,247 of 29,063 companies
33.3
score / 100
Value21
Quality46
FCF yld-2.2%
Earn yld-1.2%
EV/EBITDA45.3x
ROE-1.2%
Gross mgn71%
Net mgn-1.3%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 June 2026
Declarations5 total
5 of 5 declarations
关于 삼익제약
Samik Pharmaceutical是一家健康和制药行业的公司，在XKRX交易所上市。它专注于药品和医药产品的开发和生产。